Evidence map›Paper›PMID 35064249›Full record

Trial reportHypertension research : official journal of the Japanese Society of Hypertension2022

Anxiety, home blood pressure monitoring, and cardiovascular events among older hypertension patients during the COVID-19 pandemic.

Shuyuan Zhang, Yixuan Zhong, Lixin Wang, Xinhua Yin, Yufeng Li, Yunlan Liu, Qiuyan Dai, Anli Tong, Dongfeng Li, Liangqing Zhang and 11 more

Registry-linked trialOpen access · hybridAbstract readClinical Trial
In one paragraph

Trial report in Hypertension research : official journal of the Japanese Society of Hypertension, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03015311 (Strategy of Systolic Blood Pressure Intervention in the Elderly Hypertensive Patients), which is not on this map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03015311 naunknown statusnot on this map

Strategy of Systolic Blood Pressure Intervention in the Elderly Hypertensive Patients: A Prospective Randomized Open-Label Blinded-Endpoint Trial

TypeinterventionalSponsorChinese Academy of Medical Sciences, Fuwai HospitalRan2017 to 2021Enrolled8,000ConditionsPrimary HypertensionArmsIntensive BP control, Standard BP control
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 35 citations in OpenAlex.

  1. Gender Differences in the Association Between Depression, Anxiety and Cardiovascular Mortality in Hypertensive Patients: A Cohort Study.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2026
    Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. 2023 update and perspectives.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Review
  8. Review
  9. Impact of COVID-19 on Lifestyle: A Sample of Iranian Older Adults.Journal of applied gerontology : the official journal of the Southern Gerontological Society · 2023
    Article
  10. Review
  11. COVID-19 pandemic and hypertension: an updated report from the Japanese Society of Hypertension project team on COVID-19.Hypertension research : official journal of the Japanese Society of Hypertension · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 15 institutions in 1 country.

Shuyuan Zhang *State Key Laboratory of Cardiovascular Disease, Hypertension Center, FuWai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College & Chinese Academy of Medical Sciences, Beilishi Road 167, Xicheng District, Beijing, 100037, China.
Yixuan Zhong *State Key Laboratory of Cardiovascular Disease, Hypertension Center, FuWai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College & Chinese Academy of Medical Sciences, Beilishi Road 167, Xicheng District, Beijing, 100037, China.
Lixin Wang *The First Affiliated Hospital of Hebei North University, Hebei, 075061, China.
Xinhua Yin *Southern University of Science and Technology Hospital, Shenzhen, 518000, China.
Yufeng LiBeijing Pinggu Hospital, Beijing, 101200, China.
Yunlan LiuThe First Hospital of Kunming, Yunnan, 650011, China.
Qiuyan DaiShanghai General Hospital, Shanghai Jiaotong University, Shanghai, 200080, China.
Anli TongPeking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China.
Dongfeng LiWuxiang County People's Hospital, Shanxi, 046300, China.
Liangqing ZhangShanxi Cardiovascular Hospital, Shanxi, 030000, China.
Ping Li2nd Affiliated Hospital of Nan Chang University, Jiangxi, 330006, China.
Guohui ZhangZhenjiang First People's Hospital, Jiangsu, 212002, China.
Rongjie HuangThe First Affiliated Hospital of Guangxi Medical University, Guangxi, 530021, China.
Jinguang LiuHuizhou Municipal Central Hospital, Guangdong, 516001, China.
Luosha ZhaoFirst Affiliated Hospital of Zhengzhou University, Henan, 450000, China.
Jing YuLanzhou University Second Hospital, Gansu, 730030, China.
Xinjun ZhangWest China Hospital, Sichuan University, Sichuan, 610041, China.
Li YangYan'an Hospital affiliated Kunming Medical University, Yunnan, 650101, China.
Jun CaiState Key Laboratory of Cardiovascular Disease, Hypertension Center, FuWai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College & Chinese Academy of Medical Sciences, Beilishi Road 167, Xicheng District, Beijing, 100037, China. caijun@fuwaihospital.org.
Weili ZhangState Key Laboratory of Cardiovascular Disease, Hypertension Center, FuWai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College & Chinese Academy of Medical Sciences, Beilishi Road 167, Xicheng District, Beijing, 100037, China. zhangweili1747@yahoo.com.
STEP Study Group
Fu Wai Hospital · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNBeijing Anding Hospital · CNFirst Affiliated Hospital of Zhengzhou University · CNGuangxi Medical University · CNHarbin Medical University · CNHebei North University · CNHuizhou Central People's Hospital · CNLanzhou University Second Hospital · CNShanghai First People's Hospital · CNShanxi Cardiovascular Hospital · CNThe First Hospital of Kunming · CNWest China Hospital of Sichuan University · CNWujiang District People's Hospital · CNYan'an Hospital Affiliated To Kunming Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The global coronavirus disease 2019 (COVID-19) pandemic has led to a health crisis. It remains unclear how anxiety affects blood pressure (BP) and cardiovascular risk among older patients with hypertension. In this study, we extracted longitudinal data on home BP monitored via a smartphone-based application in 3724 elderly patients with hypertension from a clinical trial (60-80 years; 240 in Wuhan and 3484 in non-Wuhan areas) to examine changes in morning BP during the COVID-19 outbreak in China. Anxiety was evaluated using Generalized Anxiety Disorder-7 item scores. Changes in morning systolic BP (SBP) were analyzed for five 30-day periods during the pandemic (October 21, 2019 to March 21, 2020), including the pre-epidemic, incubation, developing, outbreak, and plateau periods. Data on cardiovascular events were prospectively collected for one year. A total of 262 individuals (7.0%) reported an increased level of anxiety, and 3462 individuals (93.0%) did not. Patients with anxiety showed higher morning SBP than patients without anxiety, and the between-group differences in SBP change were +1.2 mmHg and +1.7 mmHg during the outbreak and plateau periods (P < 0.05), respectively. The seasonal BP variation in winter among patients with anxiety was suppressed during the pandemic. Anxious patients had higher rates of uncontrolled BP. During the 1-year follow-up period, patients with anxiety had an increased risk of cardiovascular events with a hazard ratio of 2.47 (95% confidence interval, 1.10-5.58; P = 0.03). In summary, COVID-19-related anxiety was associated with a short-term increase in morning SBP among older patients and led to a greater risk of cardiovascular events. (ClinicalTrials. gov number, NCT03015311).

Indexed as

COVID-19HypertensionAgedAged, 80 and overAnxietyAnxiety DisordersBlood PressureBlood Pressure Monitoring, AmbulatoryHumansMiddle AgedPandemicsAnxietyCardiovascular diseaseCoronavirus disease 2019 (COVID-19)Home blood pressureSmartphone-based application

Identifiers

PMID35064249
PMCPMC8778505
OpenAlexW4206914503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.